The aim of this study was to estimate and compare the global diagnosed incidence of RCC by region over the next ten years (2019-2029) using a forecast model that incorporates the changing risk of RCC due to population aging, as well as trends in obesity and smoking prevalence.



Biotech set for good start to 2021

View Now